4.4 Article

Synchronous and metachronous primary colorectal cancers with concordant and discordant mismatch repair status

Related references

Note: Only part of the references are listed.
Article Cell Biology

Evaluating mismatch repair deficiency in colorectal cancer biopsy specimens

F. Grillo et al.

Summary: This study aims to identify the advantages, disadvantages, and potential pitfalls of MMR evaluation on biopsy tissue for colorectal cancer. The results show that biopsy specimens often have indeterminate stains, particularly for MLH1. However, this issue can be solved by reducing primary incubation times, allowing for accurate assessment of MMR status.

HISTOCHEMISTRY AND CELL BIOLOGY (2023)

Article Surgery

Metachronous colorectal cancer have a similar microsatellite instability frequency but a lower infiltration of lymphomononuclear cells than primary lesions

Imerio Angriman et al.

Summary: The study found that the frequency of microsatellite instability was similar in metachronous and sporadic colorectal cancer, while the absence of tumor-infiltrating lymphomononuclear cells may be a crucial factor leading to the occurrence of metachronous colorectal cancer.

SURGERY (2022)

Article Gastroenterology & Hepatology

Clinicopathologic characteristics and prognosis of synchronous colorectal cancer: a retrospective study

Huaxian Chen et al.

Summary: This retrospective study analyzed the clinicopathological characteristics of synchronous colorectal cancer (SCRC) and early-onset synchronous colorectal cancer (EO-SCRC) and identified their relevant prognostic factors. The results showed that SCRC occurred more frequently in elderly and male patients, while EO-SCRC was less common in SCRC patients. Patients with SCRC had lower overall survival rate compared to those with primary unifocal colorectal cancer (PCRC), but SCRC was not an independent prognostic factor for colorectal cancer (CRC). On the other hand, EO-SCRC was found to be a favorable prognostic factor for CRC and SCRC.

BMC GASTROENTEROLOGY (2022)

Article Oncology

Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study

Luis A. Diaz et al.

Summary: The final overall survival analysis of the KEYNOTE-177 study showed that while pembrolizumab continued to demonstrate durable antitumor activity and fewer treatment-related adverse events compared to chemotherapy in patients with microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer, there was no statistically significant difference in overall survival between the two treatment groups.

LANCET ONCOLOGY (2022)

Article Oncology

Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors

Enrico Berrino et al.

Summary: The presence of multiple and metachronous tumors in young patients may be associated with genetic variants. This study describes the case of a 16-year-old patient with synchronous bifocal colorectal adenocarcinoma and distant metastases. Molecular characterization and transcriptomic analysis revealed a POLE-LYNCH collision syndrome, explaining the observed ultra-mutator phenotype and MMR deficiency-associated features.

NPJ PRECISION ONCOLOGY (2022)

Article Medicine, General & Internal

Molecular Typing and Clinical Characteristics of Synchronous Multiple Primary Colorectal Cancer

Yandong Zhao et al.

Summary: This cohort study evaluated the clinical characteristics and pathogenic variations in lesions and the molecular typing of synchronous multiple primary colorectal cancer (sMPCC). The study found that the deficient mismatch repair (dMMR)/microsatellite instability-high (MSI-H) frequencies in sMPCC were significantly higher than those in single primary colorectal cancer (SPCRC). The findings also suggested that sMPCC can be classified into three subgroups according to the MMR/MSI status of each lesion, which might be applied to guide personalized therapies for better disease management.

JAMA NETWORK OPEN (2022)

Article Microbiology

Gut microbiota distinct between colorectal cancers with deficient and proficient mismatch repair: A study of 230 CRC patients

Min Jin et al.

Summary: CRC patients with different MMR status have distinct gut bacterial community richness, compositions, and related metabolic pathways.

FRONTIERS IN MICROBIOLOGY (2022)

Article Oncology

Discordant DNA mismatch repair protein status between synchronous or metachronous gastrointestinal carcinomas: frequency, patterns, and molecular etiologies

Monika Vyas et al.

Summary: The study reveals that inter-tumoral MMR discordance is not uncommon among patients with multiple primary GIT carcinomas, and may be associated with widely varied molecular etiologies. This highlights the importance of understanding these patterns in ensuring effective strategies in both LS detection and treatment decision-making. MM testing should be performed on the specific tumors being treated when selecting patients for immunotherapy.

FAMILIAL CANCER (2021)

Article Oncology

Prognostic variables in low and high risk stage III colon cancers treated in two adjuvant chemotherapy trials

Frank A. Sinicrope et al.

Summary: This study stratified patients with stage III colon cancer and found that sidedness and BRAF/MMR contributed the most to survival outcomes among high-risk tumors, while mutant KRAS was associated with poor prognosis in both low and high-risk tumors.

EUROPEAN JOURNAL OF CANCER (2021)

Article Gastroenterology & Hepatology

Retrospective study of prognosis of patients with multiple colorectal carcinomas: synchronous versus metachronous makes the difference

Christoph Barz et al.

Summary: In this analysis, a total of 3714 patients were included, with 3506 (94.4%) having primary unifocal colorectal cancer (PCRC), 103 (2.7%) having SCRC, and 105 (2.8%) having MCRC. SCRC occurred more frequently in elderly and male patients. Patients with SCRC did not show altered recurrence or survival rates, while MCRC had lower rates of recurrence and cause-specific death compared to PCRC.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2021)

Article Gastroenterology & Hepatology

Prognostic Impact and Clinicopathological Features of Multiple Colorectal Cancers and Extracolorectal Malignancies: A Nationwide Retrospective Study

Kentaro Ochiai et al.

Summary: The presence of synchronous colorectal cancers (SCRCs) was associated with synchronous extracolorectal malignancies (SEMs), which were found to be the strongest poor prognostic factor for patients with stage I-III colorectal cancer. Stomach cancer had the highest incidence among extracolorectal malignancies, and multiple colorectal cancers were evenly distributed throughout the colon.

DIGESTION (2021)

Article Gastroenterology & Hepatology

A 10-Year Evaluation of Short-Term Outcomes After Synchronous Colorectal Cancer Surgery: a Dutch Population-Based Study

A. K. Warps et al.

Summary: The study evaluated time trends in synchronous colorectal cancer patients, finding higher rates of complications and mortality among synchronous CRC surgery patients. Bilateral synchronous colon cancer required more extensive resection, resulting in significantly worse outcomes.

JOURNAL OF GASTROINTESTINAL SURGERY (2021)

Article Gastroenterology & Hepatology

Synchronous colorectal carcinoma: predisposing factors and characteristics

C. -C. Chin et al.

COLORECTAL DISEASE (2019)

Article Pathology

A Practical Approach to the Evaluation of Gastrointestinal Tract Carcinomas for Lynch Syndrome

Rish K. Pai et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)

Article Oncology

Clinical characteristics of synchronous colorectal cancers in Japan

Takaharu Kato et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2016)

Article Gastroenterology & Hepatology

Altered DNA Mismatch Repair Expression in Synchronous and Metachronous Colorectal Cancers

Harry R. Aslaniaw et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)

Article Oncology

The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers

DA Lawes et al.

BRITISH JOURNAL OF CANCER (2005)